Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis

被引：0
|
作者：
Qi Pei
Lu Huang
Jie Huang
Jing-kai Gu
Yun Kuang
Xiao-cong Zuo
Jun-jie Ding
Hong-yi Tan
Cheng-xian Guo
Shi-kun Liu
Guo-ping Yang
机构：
[1] Third Xiangya Hospital,Center of Clinical Pharmacology and Pharmacy Department
[2] Central South University,undefined
[3] Drug Metabolism Research Center of Jilin University,undefined
[4] Children's Hospital of Fudan University,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
schizophrenia; iloperidone; gene polymorphisms; 10; population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1499 / 1508
页数：9
相关论文
共 50 条
  • [41] INFLUENCE OF CYP2D6 GENETIC POLYMORPHISM ON THE PHARMACOKINETIC PARAMETERS OF RISPERIDONE AND ITS ACTIVE METABOLITES
    Byeon, J. Y.
    Kim, S. H.
    Kim, Y. H.
    Lee, H. J.
    Lee, Y.
    Lee, Y. J.
    Kim, D. H.
    Lim, H. J.
    Lee, S. Y.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E58 - E59
  • [42] Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone
    Cho, Chang-Keun
    Byeon, Ji-Young
    Kang, Pureum
    Park, Jung-In
    Jang, Choon-Gon
    Lee, Seok-Yong
    Choi, Chang-Ik
    Bae, Jung-Woo
    Lee, Yun Jeong
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (01) : 59 - 64
  • [43] Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone
    Chang‑Keun Cho
    Ji-Young Byeon
    Pureum Kang
    Jung-In Park
    Choon-Gon Jang
    Seok-Yong Lee
    Chang-Ik Choi
    Jung‑Woo Bae
    Yun Jeong Lee
    Archives of Pharmacal Research, 2023, 46 : 59 - 64
  • [44] Effect of the CYP2D6*10 Genotype on Tolterodine Pharmacokinetics
    Oishi, Masayo
    Chiba, Koji
    Malhotra, Bimal
    Suwa, Toshio
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (09) : 1456 - 1463
  • [45] Impact of CYP2D6*10 on pharmacokinetics of venlafaxine and its demethylated metabolite in Japanese psychiatric patients
    Komahashi-Sasaki, H.
    Watanabe, T.
    Inoue, Y.
    Sasaki, T.
    Shinozaki, M.
    Hayashi, Y.
    Kato, K.
    Kuroda, J.
    Yasui-Furukori, N.
    Shimoda, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S236 - S237
  • [46] Effect of CYP2D6 genetic polymorphisms on pharmacokinetics of tropisetron.
    Oh, D
    Kim, M
    Cho, J
    Lim, H
    Hong, K
    Chung, J
    Bae, K
    Yi, S
    Shin, S
    Jang, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P21 - P21
  • [47] CYP2D6 genotypes in a Japanese population:: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10
    Nishida, Y
    Fukuda, T
    Yamamoto, I
    Azuma, J
    PHARMACOGENETICS, 2000, 10 (06): : 567 - 570
  • [48] CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia:: a meta-analysis
    Patsopoulos, NA
    Ntzani, EE
    Zintzaras, E
    Ioannidis, JPA
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (03): : 151 - 158
  • [49] Effects of CYP2D6*10 and CYP2D6*5 alleles on the pharmacokinetics of carvedilol in healthy Koreans.
    Kang, Byung-Sung
    Lee, Hye-In
    Choi, Chang-Ik
    PHARMACOTHERAPY, 2012, 32 (10): : E301 - E301
  • [50] THE PHARMACOKINETICS OF PRIMAQUINE AND ITS METABOLITES IN HEALTHY CAMBODIAN ADULTS WITH VARIOUS CYP2D6 GENOTYPES
    Spring, Michele
    Vanachayangkul, Pattaraporn
    Lon, Chanthap
    Sea, Darapiseth
    Sok, Somethy
    Chann, Soklyda
    Hom, Sokhei
    Ittiverakul, Mali
    Kodchakorn, Chanikarn
    Arsanok, Montri
    Thay, Kheangheng
    Kuntawunginn, Worachet
    Saunders, David
    Rekol, Huy
    Wojnarski, Mariusz
    Smith, Philip
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 546 - 546
12345